MDA-MB-435S Cells
CAD$545.10*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | Disclaimer: The cell line in question has been identified as problematic due to contamination issues. Specifically, the parent cell line (MDA-MB-435) has been shown to be a derivative of the M14 cell line. The MDA-MB-435S cell line is a widely utilized model in cancer research, originally thought to be derived from a breast cancer metastasis. These cells exhibit characteristics typical of highly aggressive cancer cells, including a rapid proliferation rate, resistance to apoptosis, and the ability to invade surrounding tissues. Due to these traits, MDA-MB-435S cells are frequently used in studies investigating cancer metastasis, drug resistance mechanisms, and the molecular underpinnings of aggressive tumor behavior. Interestingly, subsequent molecular and genetic analyses have revealed that MDA-MB-435S cells share a closer genetic profile with melanoma rather than breast cancer, raising significant implications for their use in research. Despite this controversy, they remain a valuable model for studying metastatic processes and testing potential therapeutic agents, particularly those targeting mechanisms common to both breast cancer and melanoma. Researchers are advised to consider these genetic findings when interpreting results obtained from studies involving MDA-MB-435S cells. |
|---|---|
| Organism | Human |
| Tissue | Skin |
| Disease | Amelanotic melanoma |
| Metastatic site | Right buttock, hypodermis |
| Synonyms | MDA-MB-435s, MDA-MB-435 S, MDA-MB-435-S, MDAMB435S, BrCL15 |
Characteristics
| Age | 33 years |
|---|---|
| Gender | Male |
| Ethnicity | European |
| Morphology | Pleomorphic and multinucleated cells |
| Growth properties | Adherent |
Regulatory Data
| Citation | MDA-MB-435S (Cytion catalog number 300277) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0622 |
Biomolecular Data
Handling
| Culture Medium | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| Supplements | Supplement the medium with 5% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300277-712 | Certificate of Analysis | 23. May. 2025 | 300277 |
-
Related products
Related products
MDA-MB-175-VII CellsOrganism Human Tissue Metastatic Disease Invasive breast carcinoma of no special type CAD$759.00*